Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with SNY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.01%||Market Vectors Pharmaceutical ETF (PPH)||-5.82 (-8.06%)|
|3.48%||BLDRS Europe 100 ADR Index Fund (ADRU)||-2.02 (-8.70%)|
|3.21%||WBI Large Cap Tactical Yield Shares (WBIG)||-2.35 (-9.65%)|
|3.17%||WBI Large Cap Tactical Value Shares (WBIF)||-1.65 (-6.72%)|
|2.81%||BLDRS Developed Markets 100 ADR Index Fund (ADRD)||-2.41 (-10.13%)|
Company Description (as filed with the SEC)
Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. In 2014, our net sales were €33,770 million. We are the fourth largest pharmaceutical group in the world and the second largest in Europe in terms of sales (IMS data). Sanofi is the parent company of a consolidated group of companies. A list of our principal subsidiaries can be found in Note F to our consolidated financial statements included at Item 18 of this annual report. The Group is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. These activities are operating segments within the meaning of the IFRS 8 accounting standard (see Note D.35. to the consolidated financial statements). We invest in the following activities (see "B. Business Overview -- B.1. ... More ...
Where does SNY fit in the risk graph?
|Annual EPS Est:||$2.98|
|Quarterly EPS Est:||0.87|